|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005516,
umls-concept:C0007131,
umls-concept:C0017337,
umls-concept:C0026882,
umls-concept:C0681890,
umls-concept:C0871261,
umls-concept:C1268567,
umls-concept:C1414313,
umls-concept:C1517378,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1948062,
umls-concept:C2757011,
umls-concept:C2911692
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-1-5
|
|
pubmed:abstractText |
The aim of this systematic review and meta-analysis was to characterize common EGFR molecular aberrations as potential predictive biomarkers for response to monotherapy with tyrosine kinase inhibitors (TKI) in non-small cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
291-303
|
|
pubmed:meshHeading |
pubmed-meshheading:20028749-Biological Markers,
pubmed-meshheading:20028749-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:20028749-Gene Dosage,
pubmed-meshheading:20028749-Humans,
pubmed-meshheading:20028749-Lung Neoplasms,
pubmed-meshheading:20028749-Mutation,
pubmed-meshheading:20028749-Prognosis,
pubmed-meshheading:20028749-Protein Kinase Inhibitors,
pubmed-meshheading:20028749-Receptor, Epidermal Growth Factor,
pubmed-meshheading:20028749-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non-small cell lung cancer.
|
|
pubmed:affiliation |
Department of Pathophysiology, Medical School, National University of Athens, Athens, Greece.
|
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
